Advanced Flower Capital Inc. 10-Q

Item 1. Financial Statements AFC GAMMA, INC. BALANCE SHEETS As Of June 30, 2021 December 31, 2020 (unaudited) Assets Loans held for investment at fair value (cost of $ 43,916,537 and $ 46,994,711 at June 30, 2021 and December 31, 2020, respectively, net) $ 44,852,315 $ 48,558,051 Loans held for investment at carrying value 105,404,185 31,837,031 Loan receivable at carrying value 3,011,140 3,348,263 Current expected credit loss reserve ( 701,143 ) ( 404,860 ) Loans held for investment at carrying value and loan receivable at carrying value, net of current expected credit loss reserve 107,714,182 34,780,434 Cash and cash equivalents 124,604,872 9,623,820 Interest receivable 1,150,669 927,292 Prepaid expenses and other assets 189,000 72,095 Total assets $ 278,511,038 $ 93,961,692 Liabilities Interest reserve $ 5,547,863 $ 1,325,750 Current expected credit loss reserve 476,140 60,537 Accrued management and incentive fees 2,078,871 222,127 Accrued direct administrative expenses 530,939 550,671 Accounts payable and other liabilities 1,420,503 154,895 Total liabilities 10,054,316 2,313,980 Commitments and contingencies (Note 10) Stockholders' Equity Preferred stock, par value $ 0.01 per share, 10,000 shares authorized at June 30, 2021 and December 31, 2020 and 125 shares issued and outstanding at June 30, 2021 and December 31, 2020 1 1 Common stock, par value $ 0.01 per share, 25,000,000 and 15,000,000 shares authorized at June 30, 2021 and December 31, 2020, respectively, and 16,116,877 and 6,179,392 shares issued and outstanding at June 30, 2021 and December 31, 2020, respectively 161,169 61,794 Additional paid-in-capital 269,061,069 91,068,197 Accumulated earnings (deficit) ( 765,517 ) 517,720 Total stockholders' equity 268,456,722 91,647,712 Total liabilities and stockholders' equity $ 278,511,038 $ 93,961,692 (See accompanying notes to the Financial Statements) 1 Index AFC GAMMA, INC. STATEMENTS OF OPERATIONS For the three months ended June 30, 2021 For the six months ended June 30, 2021 (unaudited) (unaudited) Revenue Interest Income $ 8,748,519 $ 13,433,524 Total revenue 8,748,519 13,433,524 Expenses Management and incentive fees, net (less rebate of $ 182,707 and $ 420,450 , respectively) 2,078,871 2,955,533 General and administrative expenses 706,865 1,169,383 Stock-based compensation 11,457 1,610,572 Professional fees 194,594 330,047 Total expenses 2,991,787 6,065,535 Provision for current expected credit losses ( 645,786 ) ( 711,886 ) Change in unrealized gains / (losses) on loans at fair value, net ( 483,159 ) ( 627,561 ) Net income before income taxes 4,627,787 6,028,542 Income tax expense - - Net income $ 4,627,787 $ 6,028,542 Earnings per common share: Basic earnings per common share (in dollars per share) $ 0.34 $ 0.58 Diluted earnings per common share (in dollars per share) $ 0.34 $ 0.57 Weighted average number of common shares outstanding: Basic weighted average shares of common stock outstanding (in shares) 13,457,536 10,318,542 Diluted weighted average shares of common stock outstanding (in shares) 13,775,246 10,636,252 (See accompanying notes to the Financial Statements) 2 Index AFC GAMMA, INC. STATEMENTS OF STOCKHOLDERS’ EQUITY (unaudited) Three months ended June 30, 2021 Preferred Stock Common Stock Additional Paid- In-Capital Accumulated Earnings (Deficit) Total Stockholders' Equity Shares Amount Balance at March 31, 2021 $ 1 13,366,877 $ 133,669 $ 216,504,726 $ ( 306,391 ) $ 216,332,005 Issuance of common stock, net of offering cost - 2,750,000 27,500 52,544,886 - 52,572,386 Stock-based compensation - - - 11,457 - 11,457 Dividends declared and paid on common shares ($ 0.38 per share) - - - - ( 5,079,413 ) ( 5,079,413 ) Dividends declared and paid on preferred shares ($ 60 per share) - - - - ( 7,500 ) ( 7,500 ) Net income - - - - 4,627,787 4,627,787 Balance at June 30 , 2021 $ 1 16,116,877 $ 161,169 $ 269,061,069 $ ( 765,517 ) $ 268,456,722 Six months ended June 30, 2021 Preferred Stock Common Stock Additional Paid- In-Capital Accumulated Earnings (Deficit) Total Stockholders' Equity Shares Amount Balance at December 31, 2020 $ 1 6,179,392 $ 61,794 $ 91,068,197 $ 517,720 $ 91,647,712 Issuance of common stock, net of offering cost - 9,937,485 99,375 176,382,300 - 176,481,675 Stock-based compensation - - - 1,610,572 - 1,610,572 Dividends declared and paid on common shares ($ 0.74 per share) - - - - ( 7,304,279 ) ( 7,304,279 ) Dividends declared and paid on preferred shares ($ 60 per share) - - - - ( 7,500 ) ( 7,500 ) Net income - - - - 6,028,542 6,028,542 Balance at June 30 , 2021 $ 1 16,116,877 $ 161,169 $ 269,061,069 $ ( 765,517 ) $ 268,456,722 (See accompanying notes to the Financial Statements) 3 Index AFC GAMMA, INC. STATEMENT OF CASH FLOWS For the six months ended June 30, 2021 Operating activities: (unaudited) Net income $ 6,028,542 Adjustments to reconcile net income / (loss) to net cash provided by / (used in) operating activities: Provision for current expected credit losses 711,886 Change in unrealized gains / (losses) on loans at fair value, net 627,561 Accretion of deferred loan original issue discount and other discounts ( 2,275,032 ) Stock-based compensation 1,610,572 PIK interest ( 1,267,093 ) Changes in operating assets and liabilities: Interest reserve ( 702,887 ) Interest receivable ( 223,377 ) Prepaid expenses and other assets ( 116,905 ) Accrued management fees, net 1,856,744 Accrued direct administrative expenses ( 19,732 ) Accounts payable and other liabilities 1,265,608 Net cash provided by / (used in) operating activities 7,495,887 Cash flows from investing activities: Issuance of and fundings on loans ( 76,918,926 ) Proceeds from sales of Assigned Rights 2,313,130 Principal repayment of loans 12,921,065 Net cash provided by / (used in) investing activities ( 61,684,731 ) Cash flows from financing activities: Proceeds from sale of common stock 180,277,500 Payment of offering costs ( 3,795,825 ) Dividends paid ( 7,311,779 ) Net cash provided by / (used in) financing activities 169,169,896 Change in cash, cash equivalents and restricted cash 114,981,052 Cash, cash equivalents and restricted cash, beginning of period 9,623,820 Cash, cash equivalents and restricted cash, end of period $ 124,604,872 Supplemental disclosure of non-cash financing and investing activity: Interest reserve withheld from funding of loan $ 4,925,000 Supplemental information: Interest paid during the period $ - Income taxes paid during the period $ - (See accompanying notes to the Financial Statements) 4 Index AFC GAMMA, INC. NOTES TO FINANCIAL STATEMENTS As of June 30, 2021 (unaudited) 1. ORGANIZATION AFC Gamma, Inc. (the “Company” or “AFCG”) is a commercial real estate (“CRE”) finance company primarily engaged in originating, structuring, and underwriting senior secured loans and other types of loans. The Company was formed and commenced operations on July 31, 2020. The Company is a Maryland corporation and completed its initial public offering (the “IPO”) in March 2021. The Company is externally managed by AFC Management, LLC (“AFC Management” or the Company’s “Manager”), a Delaware limited liability company, pursuant to the terms of a management agreement (as amended, the “Management Agreement”). The Company operates as one operating segment and is primarily focused on financing senior secured loans and other types of loans for established cannabis industry operators in states where medical and/or adult use cannabis is legal. These loans are generally held for investment and are secured, directly or indirectly, by real estate, equipment, licenses and/or other assets of borrowers depending on the applicable laws and regulations governing such borrowers. The Company intends to elect to be taxed as a real estate investment trust (“REIT”) for United States federal income tax purposes under the Internal Revenue Code of 1986, as amended (the “Code”), commencing with its taxable year ended December 31, 2020. The Company generally will not be subject to United States federal income taxes on its REIT taxable income as long as it annually distributes all of its REIT taxable income prior to the deduction for dividends paid to stockholders and complies with various other requirements as a REIT. 2. SIGNIFICANT ACCOUNTING POLICIES The accompanying unaudited interim financial statements should be read in conjunction with the audited financial statements and the related management's discussion and analysis of financial condition and results of operations included in the Company's final prospectus relating to our follow-on public offering filed with the Securities and Exchange Commission (“SEC”) in accordance with Rule 424(b) of the Securities Act of 1933, as amended (the “Securities Act”) on June 24, 2021 (the “Final Prospectus”). Refer to Note 2 to the Company’s financial statements in the Final Prospectus for a description of the Company’s significant accounting policies. The Company has included disclosure below regarding basis of presentation and other accounting policies that (i) are required to be disclosed quarterly, (ii) have material changes or (ii) the Company views as critical as of the date of this report. Basis of Presentation The accompanying unaudited interim financial statements and related notes have been prepared on the accrual basis of accounting in conformity with United States generally accepted accounting principles (“GAAP”) and in conformity with the rules and regulations of the SEC applicable to interim financial information. These unaudited interim financial statements reflect all adjustments and reclassifications that, in the opinion of management, are considered necessary for a fair statement of the balance sheets, statements of operations, statements of stockholders’ equity, and statement of cash flows for the periods presented. The current period’s results of operations will not necessarily be indicative of results that ultimately may be achieved for the year ending December 31, 2021. 5 Index Use of Estimates in the Preparation of Financial Statements The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Actual results could differ from those estimates. Significant estimates include the valuation of loans held for investment at fair value. The spread of a novel strain of coronavirus (“COVID-19”) has caused significant business disruptions in the United States beginning in the first quarter of 2020 and has resulted in governmental authorities implementing numerous measures to try to contain the virus, such as quarantines, shelter-in-place or total lock-down orders and business limitations and shutdowns (subject to exceptions for certain “essential” operations and businesses). Over the course of the COVID-19 pandemic, medical cannabis companies have been deemed “essential” by almost all states with legalized cannabis and stay-at-home orders. Consequently, the impact of the COVID-19 pandemic and the related regulatory and private sector response on our financial and operating results for the period ended June 30, 2021 was somewhat mitigated as all of our borrowers were permitted to continue to operate during this pandemic. Regardless, the full extent of the economic impact of the business disruptions caused by COVID-19 is uncertain. The outbreak of COVID-19 has severely impacted global economic activity and caused significant volatility and negative pressure in financial markets. The global impact of the outbreak has been rapidly evolving, and many countries, including the United States, have reacted by instituting quarantines, mandating business and school closures and restricting travel. As a result, the COVID-19 pandemic is negatively impacting almost every industry directly or indirectly, including the regulated cannabis industry. Although some of these measures have been lifted or scaled back, a recent resurgence of COVID-19 in certain parts of the world, including the United States, has resulted in the re-imposition of certain restrictions and may lead to more restrictions to reduce the spread of COVID-19. The extent of any effect that these disruptions may have on the operations and financial performance of the Company will depend on future developments, including possible impacts on the performance of the Company’s loans, general business activity, and ability to generate revenue, which cannot be determined. Recent Accounting Pronouncements In March 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Updated (“ASU”) No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying GAAP to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments apply only to contracts, hedging relationships, and other transactions that reference the London Interbank Offered Rate (“LIBOR”) or another reference rate expected to be discontinued because of reference rate reform. ASU No. 2020-04 is effective for all entities as of March 12, 2020 through December 31, 2022. The Company is currently evaluating the impact of adopting this ASU on its financial statements. In January 2021, the FASB issued ASU No. 2021-01, Reference Rate Reform (Topic 848): Scope, which clarifies that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition. ASU No. 2021-01 is effective immediately for all entities. An entity may elect to apply the amendments on a full retrospective basis as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or on a prospective basis to new modifications from any date within an interim period that includes or is subsequent to the date of the issuance of a final update, up to the date that financial statements are available to be issued. If an entity elects to apply any of the amendments for an eligible hedging relationship, any adjustments as a result of those elections must be reflected as of the date the entity applies the election. The amendments do not apply to contract modifications made after December 31, 2022, new hedging relationships entered into after December 31, 2022, and existing hedging relationships evaluated for effectiveness in periods after December 31, 2022, except for hedging relationships existing as of December 31, 2022, that apply certain optional expedients in which the accounting effects are recorded through the end of the hedging relationship (including periods after December 31, 2022). The Company is currently evaluating the impact, if any, of this ASU on its financial statements. In October 2020, the FASB issued ASU No. 2020-08, Codification Improvements to Subtopic 310-20, Receivables-Nonrefundable Fees and Other Costs, which is an update to clarify that an entity should reevaluate whether a callable debt security is within the scope of 310-20-35-33 for each reporting period. ASU No. 2020-08 is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. Early application is not permitted. For all other entities, the amendments in ASU No. 2020-08 are effective for fiscal years beginning after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early application is permitted for all other entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. All entities should apply the amendments in this update on a prospective basis as of the beginning of the period of adoption for existing or newly purchased callable debt securities. The Company has adopted this new standard on January 1, 2021. The adoption of this standard did not have a material impact on the Company’s financial statements. 6 Index 3. LOANS HELD FOR INVESTMENT AT FAIR VALUE As of June 30, 2021 and December 31, 2020, the Company’s portfolio included three and four loans held at fair value, respectively. The aggregate originated commitment under these loans was approximately $ 47.4 million and $ 59.9 million, respectively, and outstanding principal was approximately $ 46.7 million and $ 50.8 million, respectively, as of June 30, 2021 and December 31, 2020. For the six months ended June 30, 2021, the Company funded approximately $ 7.7 million of outstanding principal and had repayments of approximately $ 12.6 million. As of June 30, 2021 and December 31, 2020, approximately 0 % and 6.0 %, respectively, of the Company’s loans held at fair value have floating interest rates. As of December 31, 2020, these floating rates were subject to LIBOR floors, with a weighted average floor of 2.5 %, calculated based on loans with LIBOR floors. References to LIBOR or “L” are to 30 -day LIBOR (unless otherwise specifically stated). The following tables summarize the Company’s loans held at fair value as of June 30, 2021 and December 31, 2020: As of June 30, 2021 Fair Value (2) Carrying Value (1) Outstanding Principal (1) Weighted Average Remaining Life (Years) (3) Senior Term Loans $ 44,852,315 $ 43,916,537 $ 46,653,209 2.6 Total loans held at fair value $ 44,852,315 $ 43,916,537 $ 46,653,209 2.6 As of December 31, 2020 Fair Value (2) Carrying Value (1) Outstanding Principal (1) Weighted Average Remaining Life (Years) (3) Senior Term Loans $ 48,558,051 $ 46,994,711 $ 50,831,235 3.3 Total loans held at fair value $ 48,558,051 $ 46,994,711 $ 50,831,235 3.3 (1) The difference between the Carrying Value and the Outstanding Principal amount of the loans consists of unaccreted purchase discount, deferred loan fees and loan origination costs. (2) Refer to Footnote 14 to our unaudited financial statements. (3) Weighted average remaining life is calculated based on the fair value of the loans as of June 30, 2021 and December 31, 2020 . 7 Index The following table presents changes in loans held at fair value as of and for the six months ended June 30, 2021 : Principal Original Issue Discount Unrealized Gains / (Losses) Fair Value Total loans held at fair value at December 31, 2020 $ 50,831,235 $ ( 3,836,524 ) $ 1,563,340 $ 48,558,051 Change in unrealized gains / (losses) on loans at fair value, net - - ( 627,561 ) ( 627,561 ) New fundings 7,677,701 ( 501,346 ) - 7,176,355 Loan repayments ( 12,000,000 ) - - ( 12,000,000 ) Loan amortization payments ( 583,324 ) - - ( 583,324 ) Accretion of original issue discount - 1,601,197 - 1,601,197 PIK Interest 727,597 - - 727,597 Total loans held at fair value at June 30, 2021 $ 46,653,209 $ ( 2,736,673 ) $ 935,779 $ 44,852,315 A more detailed listing of the Company’s loans held at fair value portfolio based on information available as of June 30, 2021 is as follows: Collateral Location Collateral Type (8) Fair Value (2) Carrying Value (1) Outstanding Principal (1) Interest Rate Maturity Date (3) Payment Terms (4) Private Co. A AZ, MI, MD, MA C , D $ 33,059,982 $ 32,543,647 $ 34,654,069 17.0 % (5) 5/8/2024 P/I Private Co. B MI C 8,909,663 8,503,029 9,059,140 17.0 % (6) 9/1/2023 P/I Public Co. A - Real Estate Loan NV C 2,882,670 2,869,861 2,940,000 14.0 % (7) 1/26/2023 I/O Total loans held at fair value $ 44,852,315 $ 43,916,537 $ 46,653,209 (1) The difference between the Carrying Value and the Outstanding Principal amount of the loans consists of unaccreted original issue discount (“OID”) and loan origination costs. (2) Refer to Footnote 14 to our unaudited financial statements. (3) Certain loans are subject to contractual extension options and may be subject to performance based or other conditions as stipulated in the loan agreement. Actual maturities may differ from contractual maturities stated herein as certain borrowers may have the right to prepay with or without paying a prepayment penalty. The Company may also extend contractual maturities and amend other terms of the loans in connection with loan modifications. (4) I/O = interest only, P/I = principal and interest. P/I loans may include interest only periods for a portion of the loan term. (5) Base interest rate of 13 % and payment-in-kind (“PIK”) interest rate of 4 %. (6) Base interest rate of 13 % and PIK interest rate of 4 %. (7) Base interest rate of 12 % and PIK interest rate of 2 %. (8) C = Cultivation Facilities, D = Dispensaries. 8 Index 4. LOANS HELD FOR INVESTMENT AT CARRYING VALUE As of June 30, 2021 and December 31, 2020, the Company’s portfolio included ten and three loans, respectively, held at carrying value. The aggregate originated commitment under these loans was approximately $ 136.3 million and $ 44.0 million, respectively, and outstanding principal was approximately $ 114.4 million and $ 33.9 million, respectively, as of June 30, 2021 and December 31, 2020. For the six months ended June 30, 2021, the Company funded approximately $ 79.9 million of outstanding principal. As of June 30, 2021 and December 31, 2020, approximately 44 % and 35 %, respectively, of the Company’s loans held at carrying value have floating interest rates. These floating rates are subject to LIBOR floors, with a weighted average floor of 1 %, calculated based on loans with LIBOR floors. References to LIBOR or “L” are to 30 -day LIBOR (unless otherwise specifically stated). The following tables summarize the Company’s loans held at carrying value as of June 30, 2021 and December 31, 2020: As of June 30, 2021 Outstanding Principal (1) Original Issue Discount Carrying Value (1) Weighted Average Remaining Life (Years) (2) Senior Term Loans $ 114,376,084 $ ( 8,971,899 ) $ 105,404,185 3.8 Total loans held at carrying value $ 114,376,084 $ ( 8,971,899 ) $ 105,404,185 3.8 As of December 31, 2020 Outstanding Principal (1) Original Issue Discount Carrying Value (1) Weighted Average Remaining Life (Years) (2) Senior Term Loans $ 33,907,763 $ ( 2,070,732 ) $ 31,837,031 4.7 Total loans held at carrying value $ 33,907,763 $ ( 2,070,732 ) $ 31,837,031 4.7 (1) The difference between the Carrying Value and the Outstanding Principal amount of the loans consists of unaccreted original issue discount and loan origination costs. (2) Weighted average remaining life is calculated based on the carrying value of the loans as of June 30, 2021 and December 31, 2020. The following table presents changes in loans held at carrying value as of and for the six months ended June 30, 2021: Principal Original Issue Discount Carrying Value Total loans held at carrying value at December 31, 2020 $ 33,907,763 $ ( 2,070,732 ) $ 31,837,031 New fundings 79,928,825 ( 7,574,384 ) 72,354,441 Accretion of original issue discount - 673,217 673,217 PIK interest 539,496 - 539,496 Total loans held at carrying value at June 30, 2021 $ 114,376,084 $ ( 8,971,899 ) $ 105,404,185 9 Index A more detailed listing of the Company’s loans held at carrying value portfolio based on information available as of June 30, 2021 is as follows: Collateral Location Collateral Type (4) Outstanding Principal (1) Original Issue Discount Carrying Value (1) Interest Rate Maturity Date (2) Payment Terms (3) Private Co. C PA C , D $ 16,571,443 $ ( 764,590 ) $ 15,806,853 17.0 % (5) 12/1/2025 P/I Private Co. D OH, AR D 12,107,055 ( 930,564 ) 11,176,491 15.0 % (6) 1/1/2026 P/I Sub. of Public Co. D PA C 10,000,000 ( 160,714 ) 9,839,286 12.9 % (7) 12/18/2024 I/O Private Co. E OH C , D 11,174,533 ( 2,936,883 ) 8,237,650 17.0 % (8) 4/1/2026 P/I Private Co. F MO C , D 6,166,025 ( 1,915,902 ) 4,250,123 17.0 % (9) 5/1/2026 P/I Public Co. E MI C 15,000,000 ( 985,714 ) 14,014,286 13.0 % (10) 4/29/2025 P/I Sub. of Private Co. G NJ C , D 22,075,778 ( 836,722 ) 21,239,056 17.0 % (11) 5/1/2026 P/I Public Co. F IL, FL, NV, OH, MA, MI, MD, AR, NV, AZ C , D 10,000,000 ( 184,000 ) 9,816,000 9.8 % (12) 5/30/2023 I/O Sub. of Private Co. H IL C 5,781,250 ( 146,810 ) 5,634,440 15.0 % (13) 5/11/2023 I/O Private Co. I MD C , D 5,500,000 ( 110,000 ) 5,390,000 13.0 % (14) 7/9/2021 I/O Total loans held at carry value $ 114,376,084 $ ( 8,971,899 ) $ 105,404,185 (1) The difference between the Carrying Value and the Outstanding Principal amount of the loans consists of unaccreted purchase discount, deferred loan fees and loan origination costs. (2) Certain loans are subject to contractual extension options and may be subject to performance based or other conditions as stipulated in the loan agreement. Actual maturities may differ from contractual maturities stated herein as certain borrowers may have the right to prepay with or without paying a prepayment penalty. The Company may also extend contractual maturities and amend other terms of the loans in connection with loan modifications. (3) I/O = interest only, P/I = principal and interest. P/I loans may include interest only periods for a portion of the loan term. (4) C = Cultivation Facilities, D = Dispensaries. (5) Base interest rate of 12 % plus LIBOR (LIBOR floor of 1 %) and PIK interest rate of 4 %. (6) Base interest rate of 13 % and PIK interest rate of 2 %. (7) Base interest rate of 12.9 %. (8) Base interest rate of 12 % plus LIBOR (LIBOR floor of 1 %) and PIK interest rate of 4 %. (9) Base interest rate of 13 % and PIK interest rate of 4 %. (10) Base interest rate of 13 %. (11) Base interest rate of 12 % plus LIBOR (LIBOR floor of 1 %) and PIK interest rate of 4 %. (12) Base interest rate of 9.8 %. (13) Base interest rate of 15 %. (14) Base interest rate of 13 %. 10 Index 5. LOAN RECEIVABLE AT CARRYING VALUE As of June 30, 2021 and December 31, 2020, the Company’s portfolio included one loan receivable at carrying value. The originated commitment under this loan was approximately $ 4.0 million and outstanding principal was approximately $ 3.0 million and $ 3.4 million as of June 30, 2021 and December 31, 2020, respectively. During the six months ended June 30, 2021, the Company received repayments of $ 337,741 of outstanding principal. The following table presents changes in loans receivable as of and for the six months ended June 30, 2021: Principal Original Issue Discount Carrying Value Total loans receivable at carrying value at December 31, 2020 $ 3,352,176 $ ( 3,913 ) $ 3,348,263 Principal repayment of loans ( 337,741 ) - ( 337,741 ) Accretion of original issue discount - 618 618 Total loans receivable at carrying value at June 30 , 2021 $ 3,014,435 $ ( 3,295 ) $ 3,011,140 6. CURRENT EXPECTED CREDIT LOSSES The Company estimates its current expected credit losses (“CECL”) on both the outstanding balances and unfunded commitments on loans held for investment and requires consideration of a broader range of historical experience adjusted for current conditions and reasonable and supportable forecast information to inform credit loss estimates (the “CECL Reserve”) using a model that considers multiple datapoints and methodologies that may include the likelihood of default and expected loss given default for each individual loan, discounted cash flows (“DCF”), and other inputs which may include the risk rating of the loan, how recently the loan was originated compared to the measurement date, and expected prepayment if applicable. Calculation of the CECL Reserve requires loan specific data, which includes fixed charge coverage ratio, loan-to-value, property type and geographic location. Estimating the CECL Reserve also requires significant judgment with respect to various factors, including (i) the appropriate historical loan loss reference data, (ii) the expected timing of loan repayments, (iii) calibration of the likelihood of default to reflect the risk characteristics of the Company’s loan portfolio and (iv) the Company’s current and future view of the macroeconomic environment. The Company may consider loan-specific qualitative factors on certain loans to estimate its CECL Reserve, which may include (i) whether cash from the borrower’s operations is sufficient to cover the debt service requirements currently and into the future, (ii) the ability of the borrower to refinance the loan and (iii) the liquidation value of collateral. For loans where we have deemed the borrower/sponsor to be experiencing financial difficulty, we may elect to apply a practical expedient in which the fair value of the underlying collateral is compared to the amortized cost of the loan in determining a Specific CECL Allowance. In order to estimate the future expected loan losses relevant to the Company’s portfolio, the Company may consider historical market loan loss data provided by a third-party data service. The third party’s loan database includes historical loss data for commercial mortgage-backed securities, or CMBS which the Company believes is a reasonably comparable and available data set to its type of loans. The Company utilized macroeconomic data that reflects a current recession; however, the short and long-term economic implications of the COVID-19 pandemic and its financial impact on the Company are highly uncertain. The CECL Reserve takes into consideration the macroeconomic impact of the COVID-19 pandemic on CRE properties and is not specific to any loan losses or impairments on the Company’s loans held for investment. As of June 30, 2021 and December 31, 2020, the Company’s CECL Reserve for its loans held at carrying value and loans receivable at carrying value is $ 1,177,283 and $ 465,397 , respectively, or 109 and 132 basis points, respectively, of the Company’s total loans held at carrying value and loans receivable at carrying value of $ 108,415,325 and $ 35,185,294 , respectively, and is bifurcated between the current expected credit loss reserve (contra-asset) related to outstanding balances on loans held at carrying value and loans receivable at carrying value of $ 701,143 and $ 404,860 , respectively, and a liability for unfunded commitments of $ 476,140 and $ 60,537 , respectively. The liability was based on the unfunded portion of the loan commitment over the full contractual period over which the Company is exposed to credit risk through a current obligation to extend credit. Management considered the likelihood that funding will occur, and if funded, the expected credit loss on the funded portion. 11 Index Activity related to the CECL Reserve for outstanding balances and unfunded commitments on the Company’s loans held at carrying value and loans receivable at carrying value as of and for the three and six months ended June 30, 2021 was as follows: Outstanding (1) Unfunded (2) Total Balance at March 31, 2021 $ 248,317 $ 283,180 $ 531,497 Provision for current expected credit losses 452,826 192,960 645,786 Write-offs - - - Recoveries - - - Balance at June 30, 2021 $ 701,143 $ 476,140 $ 1,177,283 Outstanding (1) Unfunded (2) Total Balance at December 31, 2020 $ 404,860 $ 60,537 $ 465,397 Provision for current expected credit losses 296,283 415,603 711,886 Write-offs - - - Recoveries - - - Balance at June 30, 2021 $ 701,143 $ 476,140 $ 1,177,283 (1) As of June 30, 2021 and December 31, 2020, the CECL Reserve related to outstanding balances on loans at carrying value and loans receivable at carrying value is recorded within current expected credit loss reserve in the Company's balance sheets. (2) As of June 30, 2021 and December 31, 2020, the CECL Reserve related to unfunded commitments on loans held at carrying value is recorded within other liabilities in the Company's balance sheets. The Company continuously evaluates the credit quality of each loan by assessing the risk factors of each loan and assigning a risk rating based on a variety of factors. Risk factors include property type, geographic and local market dynamics, physical condition, projected cash flow, loan structure and exit plan, loan-to-value ratio, fixed charge coverage ratio, project sponsorship, and other factors deemed necessary. Based on a 5-point scale, the Company’s loans are rated “1” through “5,” from less risk to greater risk, which ratings are defined as follows: Rating Definition 1 Very Low Risk 2 Low Risk 3 Medium Risk 4 High Risk/ Potential for Loss 5 Impaired/Loss Likely The risk ratings are primarily based on historical data as well as taking into account future economic conditions. As of June 30, 2021, the carrying value, excluding the CECL Reserve, of the Company’s loans held at carrying value and loans receivable at carrying value within each risk rating by year of origination is as follows: Risk Rating: 2021 2020 Total 1 $ - $ - $ - 2 23,830,286 - 23,830,286 3 36,513,621 45,060,278 81,573,899 4 - 3,011,140 3,011,140 5 - - - Total $ 60,343,907 $ 48,071,418 $ 108,415,325 12 Index 7. INTEREST RECEIVABLE The following table summarize the interest receivable by the Company as of June 30, 2021 and December 31, 2020: As of June 30, 2021 As of December 31, 2020 Interest receivable $ 722,716 $ 675,795 PIK receivable 362,040 177,183 Unused fees receivable 65,913 74,314 Total interest receivable $ 1,150,669 $ 927,292 8. INTEREST RESERVE At June 30, 2021 and December 31, 2020, the Company had four and one loans, respectively, that included a loan funded interest reserve. For the three and six months ended June 30, 2021, $ 620,621 and $ 702,887 , respectively, of interest income was earned and disbursed from the interest reserve. The following table presents changes in interest reserve as of and for the three and six months ended June 30, 2021: Three months ended June 30, 2021 Six months ended June 30, 2021 Beginning reserves $ 3,243,484 $ 1,325,750 New reserves 2,925,000 4,925,000 Reserves disbursed ( 620,621 ) ( 702,887 ) Ending reserves $ 5,547,863 $ 5,547,863 9. DEBT In July 2020, the Company obtained a secured revolving credit loan (the “Revolving Loan”) from AFC Finance, LLC, an affiliate of the Company’s management. The Revolving Loan had a loan commitment of $ 40,000,000 and had an interest rate of 8 % per annum, payable in cash in arrears. The Company did not incur any fees or cost related to the origination of the Revolving Loan and the Revolving Loan did not have any unused fees. The maturity date of the Revolving Loan was the earlier of (i) July 31, 2021 and (ii) the date of the closing of any credit facility where the proceeds are incurred to refund, refinance or replace the Revolving Credit Agreement (as defined below) with an aggregate principal amount equal to or greater than $ 50.0 million (any such financing, a “ Refinancing Credit Facility ”) in accordance with terms of the credit agreement governing the Revolving Loan (the “Revolving Credit Agreement”) . The Revolving Loan was secured by the assets of the Company. On May 7, 2021, the Company amended the Revolving Credit Agreement from AFC Finance, LLC, an affiliate of the Company’s management. The amendment to the Revolving Credit Agreement increased the loan commitment from $ 40,000,000 to $ 50,000,000 , decreased the interest rate from 8 % per annum to 6 % per annum, removed Gamma Lending Holdco LLC as a lender and extended the maturity date from July 31, 2021 to the earlier of (i) December 31, 2021 or (ii) the date of the closing of any Refinancing Credit Facility. The Company did not incur any fees or cost related to the amendment of the Revolving Loan and the Revolving Loan does not have any unused fees. For the three and six months ended June 30, 2021, the Company has no t drawn on the Revolving Loan or incurred any fees or interest expense related to the Revolving Loan. 13 Index 10. COMMITMENTS AND CONTINGENCIES As of June 30, 2021 and December 31, 2020, the Company had the following commitments to fund various senior term loans, equipment loans and bridge loans. As of June 30, 2021 As of December 31, 2020 Total original loan commitments $ 187,721,250 $ 107,292,176 Less: drawn commitments ( 163,721,408 ) ( 87,467,057 ) Total undrawn commitments $ 23,999,842 $ 19,825,119 The Company from time to time may be a party to litigation in the normal course of business. As of June 30, 2021, the Company is not aware of any legal claims that could materially impact its business, financial condition or results of operations. The Company provides loans to established companies operating in the cannabis industry which involves significant risks, including the risk of strict enforcement against the Company’s borrowers of the federal illegality of cannabis, the Company’s borrowers’ inability to renew or otherwise maintain their licenses or other requisite authorizations for their cannabis operations, and such loans lack of liquidity, and the Company could lose all or part of any of the Company’s loans . The Company’s ability to grow or maintain our business depends on state laws pertaining to the cannabis industry. New laws that are adverse to the Company’s borrowers may be enacted, and current favorable state or national laws or enforcement guidelines relating to cultivation, production and distribution of cannabis may be modified or eliminated in the future, which would impede the Company’s ability to grow and could materially adversely affect the Company’s business. Management’s plan to mitigate risks include monitoring the legal landscape as deemed appropriate. Also, should a loan default or otherwise be seized, the Company may be prohibited from owning cannabis assets and thus could not take possession of collateral, in which case the Company would look to sell the loan, which could result in the Company realizing a loss on the transaction. 11. STOCKHOLDERS’ EQUITY Series A Preferred Stock As of June 30, 2021 and December 31, 2020, the Company has authorized 10,000 preferred shares and issued 125 of the preferred shares designated as 12.0 % Series A Cumulative Non-Voting Preferred Stock, par value $ 0.01 per share (the “Series A Preferred Stock”). The Series A Preferred Stock entitles the holders thereof to receive cumulative cash dividends at a rate per annum of 12.0 % of the liquidation preference of $ 1,000 per share plus all accumulated and unpaid dividends thereon. The Company generally may not declare or pay, or set apart for payment, any dividend or other distribution on any shares of the Company’s stock ranking junior to the Series A Preferred Stock as to dividends, including the Company’s common stock, or redeem, repurchase or otherwise make payments on any such shares, unless full, cumulative dividends on all outstanding shares of Series A Preferred Stock have been declared and paid or set apart for payment for all past dividend periods. The holders of the Series A Preferred Stock generally have no voting rights except in limited circumstances, including certain amendments to the Company’s charter and the authorization or issuance of equity securities senior to or on parity with the Series A Preferred Stock. The Series A Preferred Stock is not convertible into shares of any other class or series of our stock. The Series A Preferred Stock is senior to all other classes and series of shares of the Company’s stock as to dividend and redemption rights and rights upon the Company’s liquidation, dissolution and winding up. Upon written notice to each record holder of the Series A Preferred Stock as to the effective date of redemption, the Company may redeem the shares of the outstanding Series A Preferred Stock at the Company’s option, in whole or in part, at any time for cash at a redemption price equal to $ 1,000 per share, for a total of $ 125,000 for the 125 shares outstanding, plus all accrued and unpaid dividends thereon to and including the date fixed for redemption, plus a redemption premium of $ 50 per share if the shares are redeemed on or before December 31, 2021. Shares of the Series A Preferred Stock that are redeemed shall no longer be deemed outstanding shares of the Company and all rights of the holders of such shares will terminate. 14 Index Common Stock The Board of Directors of the Company (the “Board”) approved a seven -for-one stock split of the Company's common stock effective on January 25, 2021. All common shares, stock options, and per share information presented in the financial statements have been adjusted to reflect the stock split on a retroactive basis for all periods presented, including reclassifying an amount equal to the increase in par value of common stock from additional paid-in capital. There was no change in the par value of the Company's common stock. Upon consummation of the Company’s IPO, any stockholder that held fractional shares received cash in lieu of such fractional shares based on the public offering price of the shares of the Company’s common stock at IPO. This resulted in the reduction of 15 shares issued and outstanding. On March 23, 2021, the Company completed its IPO of 6,250,000 shares of its common stock at a price of $ 19.00 per share, raising $ 118,750,000 in gross proceeds. The underwriters also exercised their over-allotment option to purchase up to an additional 937,500 shares of the Company’s common stock at a price of $ 19.00 per share, which was completed on March 26, 2021, raising $ 17,812,500 in additional gross proceeds. The underwriting commissions of $ 8,312,500 and $ 1,246,875 , respectively, are reflected as a reduction of additional paid-in capital on the statement of stockholders’ equity. The Company incurred approximately $ 3,093,836 of expenses in connection with the IPO, which is reflected as a reduction in additional paid-in capital. The net proceeds to the Company totaled approximately $ 123,909,289 . On June 28, 2021, the Company completed an offering of 2,750,000 shares of its common stock at a price of $ 20.50 per share, raising $ 56,375,000 in gross proceeds. The underwriting commissions of $ 3,100,625 are reflected as a reduction of additional paid-in capital on the statement of stockholders’ equity. The Company incurred approximately $ 701,989 of expenses in connection with the offering, which is reflected as a reduction in additional paid-in capital. The net proceeds to the Company totaled approximately $ 52,572,386 . Subsequent to the period ended June 30, 2021, the underwriters partially exercised their over-allotment option to purchase 269,650 shares of the Company’s common stock at a price of $ 20.50 per share, which was completed on July 6, 2021, raising $ 5,527,825 in additional gross proceeds or $ 5,223,795 in net proceeds after underwriting commissions of $ 304,030 , which is reflected as a reduction of additional paid-in capital on the statement of stockholders’ equity. The Company intends to use the net proceeds of the IPO and additional offering (i) to fund loans related to unfunded commitments to existing borrowers, (ii) to originate and participate in commercial loans to companies operating in the cannabis industry that are consistent with the Company’s investment strategy and (iii) for working capital and other general corporate purposes. Until appropriate investments can be identified, the Company may invest this balance in interest-bearing short-term investments, including money market accounts or funds, commercial mortgage-backed securities and corporate bonds, which are consistent with the Company’s intention to qualify as a REIT and to maintain our exclusion from registration under the Investment Company Act of 1940, as amended. Equity Incentive Plan The Company has established an equity incentive compensation plan (the “Plan”). The Company’s Board authorized the adoption of the Plan (as amended, the “2020 Plan”) and approved stock option grants of 1,616,098 shares of common stock as of June 30, 2021. The Board or one or more committees appointed by the Board administers the 2020 Plan. The 2020 Plan authorizes stock options, stock appreciation rights, restricted stock, stock bonuses, stock units and other forms of awards granted or denominated in the Company’s common stock or units of common stock. The 2020 Plan retains flexibility to offer competitive incentives and to tailor benefits to specific needs and circumstances. Any award may be structured to be paid or settled in cash. The Company currently intends to grant stock options to participants in the 2020 Plan, but it may also grant any other type of award available under the 2020 Plan in the future. Persons eligible to receive awards under the 2020 Plan include officers or employees of the Company or any of its subsidiaries, directors of the Company, employees of the Manager and certain directors and consultants and other service providers to the Company or any of its subsidiaries. 15 Index As of June 30, 2021, the maximum number of shares of the Company common stock that may be delivered pursuant to awards under the 2020 Plan (the “Share Limit”) equals 2,375,000 shares, which is an increase of 275,000 shares compared to March 31, 2021 under the evergreen provision in the 2020 Plan in connection with the public offering of common stock by the Company in June 2021. Subsequent to the period ended June 30, 2021, the Company issued an additional 269,650 shares of common stock to the underwriters in connection with their partial exercise of an over-allotment option, which increased the Share Limit of the 2020 Plan by 26,965 under the evergreen provision in the 2020 Plan, for a total maximum Share Limit of 2,401,965 . Shares that are subject to or underlie awards that expire or for any reason are cancelled or terminated, are forfeited, fail to vest, or for any other reason are not paid or delivered under the 2020 Plan will not be counted against the Share Limit and will again be available for subsequent awards under the 2020 Plan. Shares that are exchanged by a participant or withheld by the Company as full or partial payment in connection with any award granted under the 2020 Plan, as well as any shares exchanged by a participant or withheld by us to satisfy tax withholding obligations related to any award granted under the 2020 Plan, will not be counted against the Share Limit and will again be available for subsequent awards under the 2020 Plan. To the extent that an award is settled in cash or a form other than shares, the shares that would have been delivered had there been no such cash or other settlement will not be counted against the Share Limit and will again be available for subsequent awards under the 2020 Plan. The exercise price of any options granted under the 2020 Plan will be at net asset value or greater; provided, however, the exercise price will be at least equal to the market price of the underlying shares on the grant date. The options granted under the 2020 Plan have an ordinary term of up to ten years . An option may either be an incentive stock option or a nonqualified stock option. Options generally may not be transferred to third parties for value and do not include dividend equivalent rights. The following table summarizes the (i) non-vested options granted, (ii) vested options granted and (iii) forfeited options granted for the Company’s directors and officers and employees of the Manager as of June 30, 2021 and December 31, 2020: As of June 30, 2021 As of December 31, 2020 Non-vested 183,114 142,814 Vested 1,449,518 800,618 Forfeited ( 19,534 ) ( 16,534 ) Balance 1,613,098 926,898 The Company uses the Black-Scholes option pricing model to value stock options in determining the share-based compensation expense. Forfeitures are recognized as they occur. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the date of grant. The expected dividend yield was based on the Company’s expected dividend yield at grant date. Expected volatility is based on the estimated average volatility of similar companies due to the lack of historical volatilities of the Company’s common stock. The share-based compensation expense for the Company was approximately $ 11,457 and $ 1,610,572 for the three and six months ended June 30, 2021, respectively. The following table presents the assumptions used in the option pricing model of options granted under the 2020 Plan: Assumptions Range Expected volatility 40 % - 50 % Expected dividend yield 10 % - 20 % Risk-free interest rate 0.5 % - 1.5 % Expected forfeiture rate 0 % The following tables summarizes stock option activity during the three and six months ended June 30, 2021: Three months ended June 30, 2021 Weighted-Average Grant Date Fair Value Per Option Balance as of March 31, 2021 1,616,098 $ 1.08 Granted - - Exercised - - Forfeited ( 3,000 ) 1.31 Balance as of June 30, 2021 1,613,098 $ 1.08 16 Index Six months ended June 30, 2021 Weighted-Average Grant Date Fair Value Per Option Balance as of December 31, 2020 926,898 $ 0.91 Granted 689,200 1.31 Exercised - - Forfeited ( 3,000 ) 1.31 Balance as of June 30, 2021 1,613,098 $ 1.08 12. EARNINGS PER SHARE T he following information sets forth the computations of basic weighted average earnings per common share for the three and six months ended June 30, 2021: Three months ended June 30, 2021 Six months ended June 30, 2021 Net income / (loss) attributable to common stockholders $ 4,627,787 $ 6,028,542 Divided by: Basic weighted average shares of common stock outstanding 13,457,536 10,318,542 Diluted weighted average shares of common stock outstanding 13,775,246 10,636,252 Basic weighted average earnings per common share $ 0.34 $ 0.58 Diluted weighted average earnings per common share $ 0.34 $ 0.57 13. INCOME TAX The income tax provision for the Company was $ 0 for the six months ended June 30, 2021. For the three and six months ended June 30, 2021, the Company incurred no expense for United States federal excise tax. Excise tax represents a 4 % tax on the sum of a portion of the Company’s ordinary income and net capital gains not distributed during the period. If it is determined that an excise tax liability exists for the current period, the Company will accrue excise tax on estimated excess taxable income as such taxable income is earned. The expense is calculated in accordance with applicable tax regulations. The Company does no t have any unrecognized tax benefits and the Company does not expect that to change in the next 12 months. 14. FAIR VALUE The Company’s loans are typically valued using a yield analysis, which is typically performed for non-credit impaired loans to borrowers where the Company does not own a controlling equity position. To determine fair value using a yield analysis, a current price is imputed for the loan based upon an assessment of the expected market yield for a similarly structured loan with a similar level of risk. In the yield analysis, the Company considers the current contractual interest rate, the maturity and other terms of the loan relative to risk of the company and the specific loan. A key determinant of risk, among other things, is the leverage through the loan relative to the enterprise value of the borrower. As loans held by the Company are substantially illiquid with no active loan market, the Company depends on primary market data, including newly funded loans, as well as secondary market data with respect to high yield debt instruments and syndicated loans, as inputs in determining the appropriate market yield, as applicable. 17 Index The following tables summarize the significant unobservable inputs the Company used to value the loans categorized within Level 3 as of June 30, 2021 and December 31, 2020. The tables are not intended to be all-inclusive, but instead capture the significant unobservable inputs relevant to the Company’s determination of fair values. As of June 30, 2021 Unobservable Input Fair Value Primary Valuation Techniques Input Estimated Range Weighted Average Senior Term Loans $ 44,852,315 Yield analysis Market Yield 17.21 % - 20.47 % 20.24 % Total Investments $ 44,852,315 As of December 31, 2020 Unobservable Input Fair Value Primary Valuation Techniques Input Estimated Range Weighted Average Senior Term Loans $ 48,558,051 Yield analysis Market Yield 15.79 % - 20.75 % 20.20 % Total Investments $ 48,558,051 Changes in market yields may change the fair value of certain of the Company’s loans. Generally, an increase in market yields may result in a decrease in the fair value of certain of the Company’s loans. Due to the inherent uncertainty of determining the fair value of loans that do not have a readily available market value, the fair value of the Company’s loans may fluctuate from period to period. Additionally, the fair value of the Company’s loans may differ significantly from the values that would have been used had a ready market existed for such loans and may differ materially from the values that the Company may ultimately realize. Further, such loans are generally subject to legal and other restrictions on resale or otherwise are less liquid than publicly traded securities. If the Company was required to liquidate a loan in a forced or liquidation sale, it could realize significantly less than the value at which the Company has recorded it. In addition, changes in the market environment and other events that may occur over the life of the loans may cause the gains or losses ultimately realized on these loans to be different than the unrealized gains or losses reflected in the valuations currently assigned. The following tables present fair value measurements of loans held at fair value as of June 30, 2021 and December 31, 2020: Fair Value Measurement Using as of June 30, 2021 Total Level 1 Level 2 Level 3 Loans held at fair value $ 44,852,315 - - $ 44,852,315 Total $ 44,852,315 - - $ 44,852,315 Fair Value Measurement Using as of December 31, 2020 Total Level 1 Level 2 Level 3 Loans held at fair value $ 48,558,051 - - $ 48,558,051 Total $ 48,558,051 - - $ 48,558,051 18 Index The following table presents changes in loans that use Level 3 inputs as of and for the six months ended June 30, 2021: Six months ended June 30, 2021 Total loans using Level 3 inputs at December 31 , 2020 $ 48,558,051 Change in unrealized gains / (losses) on loans at fair value, net ( 627,561 ) Additional funding 7,677,701 Original issue discount and other discounts, net of costs ( 501,346 ) Loan repayments ( 12,000,000 ) Loan amortization payments ( 583,324 ) Accretion of original issue discount 1,601,197 PIK Interest 727,597 Total loans using Level 3 inputs at June 30 , 2021 $ 44,852,315 Fair Value of Financial Instruments GAAP requires disclosure of fair value information about financial instruments, whether or not recognized at fair value in the balance sheet, for which it is practicable to estimate that value. The following table details the book value and fair value of the Company’s financial instruments not recognized at fair value in the balance sheet: As of June 30, 2021 Carrying Value Fair Value Financial assets Cash and cash equivalents $ 124,604,872 $ 124,604,872 Loans held for investment at carrying value $ 105,404,185 $ 110,407,362 Loan receivable at carrying value $ 3,011,140 $ 2,868,235 Estimates of fair value for cash and cash equivalents are measured using observable, quoted market prices, or Level 1 inputs. All other fair value significant estimates are measured using unobservable inputs, or Level 3 inputs. 15. RELATED PARTY TRANSACTIONS Management Agreement Pursuant to the Management Agreement, the Manager manages the loans and day-to-day operations of the Company, subject at all times to the further terms and conditions set forth in the Management Agreement and such further limitations or parameters as may be imposed from time to time by the Company’s Board. The Manager will receive base management fees (the “Base Management Fee”) that are calculated and payable quarterly in arrears, in an amount equal to 0.375 % of the Company’s Equity (as defined below), subject to certain adjustments, less 50 % of the aggregate amount of any other fees (“Outside Fees”), including any agency fees relating to our loans, but excluding the Incentive Compensation (as defined below) and any diligence fees paid to and earned by the Manager and paid by third parties in connection with the Manager's due diligence of potential loans. Prior to the IPO, the quarterly base management fee was equal to 0.4375 % of the Company’s Equity, subject to certain adjustments, less 100 % of the aggregate amount of any Outside Fees, including any agency fees relating to our loans, but excluding the Incentive Compensation and any diligence fees paid to and earned by the Manager and paid by third parties in connection with the Manager's due diligence of potential loans. 19 Index In addition to the Base Management Fee, the Manager is entitled to receive incentive compensation (the “Incentive Compensation” or “Incentive Fees”) under the Management Agreement. Under the Management Agreement, the Company will pay Incentive Fees to the Manager based upon the Company’s achievement of targeted levels of Core Earnings. “Core Earnings” is defined in the Management Agreement as, for a given period means the net income (loss) for such period, computed in accordance with GAAP, excluding (i) non-cash equity compensation expense, (ii) the Incentive Compensation, (iii) depreciation and amortization, (iv) any unrealized gains or losses or other non-cash items that are included in net income for the applicable reporting period, regardless of whether such items are included in other comprehensive income or loss, or in net income and (v) one-time events pursuant to changes in GAAP and certain non-cash charges, in each case after discussions between the Manager and the Company’s independent directors and approved by a majority of the independent directors. The Incentive Compensation for the three and six months ended June 30, 2021 was approximately $ 1,442,047 and $ 2,104,777 , respectively. The Company shall pay all of its costs and expenses and shall reimburse the Manager or its affiliates for expenses of the Manager and its affiliates paid or incurred on behalf of the Company, excepting only those expenses that are specifically the responsibility of the Manager pursuant to the Management Agreement. The following table summarizes the related party costs incurred by the Company for the three and six months ended June 30, 2021: Three months ended June 30, 2021 Six months ended June 30, 2021 Affiliate Costs Management fees $ 819,531 $ 1,271,206 Less other fees earned ( 182,707 ) ( 420,450 ) Incentive fees earned 1,442,047 2,104,777 General and administrative expenses reimbursable to Manager 423,939 789,506 Total $ 2,502,810 $ 3,745,039 Amounts payable to the Company’s Manager as of June 30, 2021 and December 31, 2020 were $ 2,609,810 and $ 728,298 , respectively. Investments in Loans From time to time, the Company may co-invest with other investment vehicles managed by the Company’s Manager or its affiliates, including the Manager, and their portfolio companies, including by means of splitting loans, participating in loans or other means of syndicating loans. The Company is not obligated to provide, nor has it provided, any financial support to the other managed investment vehicles. As such, the Company’s risk is limited to the carrying value of its investment in any such loan. As of and for the six months ended June 30, 2021, there were no co-investments held by the Company. In connection with investments in loans, the Company may receive the option to assign the right (the “Assigned Right”) to acquire warrants and/or equity of the borrower. The Company may sell the Assigned Right, and the sale may be to an affiliate of the Company. For the three and six months ended June 30, 2021, the Company sold approximately $ 1,104,914 and $ 2,313,130 , respectively, of Assigned Rights to an affiliate which are accounted for as additional original issue discount and accreted over the life of the loans. Secured Revolving Credit From Affiliate The Company has the Revolving Loan from AFC Finance, LLC, an affiliate of the Company’s management. Refer to footnote 9 to our unaudited financial statements for more information. 20 Index 16. DIVIDENDS AND DISTRIBUTIONS The following table summarizes the Company’s dividends declared and paid during the six months ended June 30, 2021: Record Date Payment Date Common Share Distribution Amount Taxable Ordinary Income Return of Capital Section 199A Dividends Regular cash dividend 3/15/2021 3/31/2021 $ 0.36 $ 0.36 $ - $ 0.36 Regular cash dividend 6/15/2021 6/30/2021 $ 0.38 $ 0.38 $ - $ 0.38 Total cash dividend $ 0.74 $ 0.74 $ - $ 0.74 17. SUBSEQUENT EVENTS The Company has evaluated subsequent events through the date the financial statements were available to be issued. There were no material subsequent events, other than that described below, that required disclosure in these financial statements. Subsequent to quarter end, the underwriters partially exercised their over-allotment option under the Company’s follow-on public offering to purchase 269,650 shares of the Company’s common stock at a price of $ 20.50 per share, which was completed on July 6, 2021. Refer to footnote 11 to our unaudited financial statements for more information. In July 2021, the Company entered into a commitment to fund a $ 19.75 million senior secured term loan which is contingent on the borrower raising additional equity as required by the loan agreement. Until the borrower meets the required criteria in the loan agreement, the commitment has a ticking fee based on the aggregate commitment amount as follows: (a) 6.0 % from the date of closing through July 26, 2021 and (b) 6.5 % from and after July 27, 2021 through August 9, 2021 or the initial funding date, whichever is earlier. Once funded, the loan will have a per annum interest rate of 12.0 % plus LIBOR with a LIBOR floor of 1.0 %. The loan will have a maturity date of August 3, 2026 , an unused fee of 3.0 %, an exit fee of 3.0 %, OID of 4.0 % and an interest reserve of $ 0.75 million. In July 2021, Private Company I refinanced their bridge loan which had a maturity date of July 9, 2021 which had an interest rate of 13.0 % and OID of 4.0 %. The new senior secured loan of $ 15.5 million was syndicated by the Company’s Manager between the Company and A BDC Warehouse, LLC (“ABW”), an affiliate of the Company that is wholly-owned by Mr. and Mrs. Tannenbaum, with ABW holding approximately one-third of the principal amount . The Company committed and funded approximately $ 10.1 million of the new loan which has a per annum interest rate of 12.0 % plus LIBOR, with a LIBOR floor of 1.0 %, and PIK interest rate of 2.5 %. The loan has a maturity date of August 1, 2026 , an exit fee of 3.0 % and OID of 4.0 %. As part of the refinancing agreement, the exit fee on the bridge loan was waived and the borrower was credited for a portion of the original OID on the bridge loan. In July 2021, the Company entered into a commitment to fund a $ 3.0 million bridge loan and funded $ 3.0 million at closing. The loan has an interest rate of 13.0 %, a maturity date of August 31, 2021 , an exit fee of 10.0 % which is reduced to 2.0 % upon refinancing the loan with a senior secured loan with the Company, and OID of 4.0 %. In July 2021, Flower Loan Holdco, LLC, an affiliated entity in which Mr. Tannenbaum is the majority ultimate beneficial owner (“FLH”), purchased approximately $ 8.5 million of the senior secured credit facility with Private Company A from a third-party lender, and the Company has a 30 -day option to purchase such amount from FLH. The Company and the Company’s Manager, as agent, subsequently amended and restated the senior secured credit facility with Private Company A to, among other things, increase the loan amount by $ 10.0 million, which the agent syndicated to ABW. The amendment also allows for the borrower to draw up to an additional $ 20 million from a designee of the agent, subject to the agent’s satisfaction that certain conditions have been met. Separately, FLH entered into a new credit facility with Private Company A under which the borrower may draw up to $ 40.0 million (the “Bridge Loan”), which is secured by collateral separate from collateral securing the Company’s credit facility. In connection with the Bridge Loan and a related equity raise by Private Company A (the “Equity Raise”), the Manager or its designees are entitled to (i) appoint three of the seven members of Private Company A’s board of directors and (ii) receive a number of warrants to purchase common stock of Private Company A. In connection with the Equity Raise, an investment vehicle controlled by Jonathan Kalikow, one of the Company’s directors and executive officers, acquired approximately 8.8 % of the equity interest of Private Company A on a fully-diluted basis. Following the transactions described above, Mr. Kalikow beneficially held or controlled through investment vehicles a total of approximately 10.1 % of Private Company A’s equity interest on a fully-diluted basis. As of the date of these transactions, Mr. Tannenbaum beneficially held approximately 16.7 % of Private Company A’s equity interest on a fully-diluted basis through investment vehicles, which amount reflects two acquisitions of additional equity of Private Company A from third-party stockholders during the three months ended June 30, 2021. Following the transactions described above, Mr. Tannenbaum beneficially held approximately 21.8 % of Private Company A’s equity interest on a fully-diluted basis through investment vehicles. Given Mr. Tannenbaum’s equity ownership, each of the transactions with Private Company A described above were reviewed and approved by the Company’s Audit & Valuation Committee of the Board in accordance with the Company’s Amended and Restated Code of Business Conduct and Ethics and its Related-Persons Transaction Policy. 21 Index